Latest News & Features
article
Judge Albright awards punitive damages due to the 'intentional' nature of the infringement | Ravgen fails to secure a three-fold increase on damages awarded by a US jury last year. 16 May 2023
Big Pharma
The dispute centred on a treatment that helps people adjust their circadian rhythm | Path now clear for generic drug makers to unveil biosimilar versions of the drug. 11 May 2023
Big Pharma
Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents. 11 May 2023
Africa
Government-led schemes to incentivise patents are leading to delays and prejudice against legitimate applicants. Tyron Grant of Spoor and Fisher explains how South Africa is tackling the problem. 9 May 2023
Americas
Decision addresses issue of plausibility in invalidation verdict |
Case marks first time that Court of Appeal judges held a patent with a single claim to a pharma compound invalid. 9 May 2023
article
The new CEO is currently Denmark CEO and group VP for the firm, who has ‘spearheaded international growth efforts’. 9 May 2023
Americas
Lawsuit concerns multibillion-dollar bone-strengthening drugs |
Alleged dearth of information provided to patent owner before biologics licence application was approved. 4 May 2023
Americas
Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x. 4 May 2023
article
Latest instalment in dispute over Apple Watch health functionality ends in mistrial | Verdict inconclusive as one out of seven jurors disagrees | Masimo had asked for more than $1.8 billion in damages. 2 May 2023
Americas
Judge enters default judgment as New Jersey-based firm failed to respond to suit | Defendant allegedly sought to sell 3M-branded masks at inflated prices during the pandemic. 2 May 2023